Lymphomas
AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)
- Details
ClinicalTrials.gov ID:
NCT05207670
Diagnosis Type:
NA
USOR Number:
- Address
6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80923
P: (719) 577-2555